Related references
Note: Only part of the references are listed.Safety of Liver Gene Transfer Following Peripheral Intravascular Delivery of Adeno-Associated Virus (AAV)-5 and AAV-6 in a Large Animal Model
Patricia Favaro et al.
HUMAN GENE THERAPY (2011)
Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver Cancer
Lucia Vanrell et al.
MOLECULAR THERAPY (2011)
Sustained Enzymatic Correction by rAAV-Mediated Liver Gene Therapy Protects Against Induced Motor Neuropathy in Acute Porphyria Mice
Carmen Unzu et al.
MOLECULAR THERAPY (2011)
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin et al.
HUMAN GENE THERAPY (2010)
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
Francesca Simonelli et al.
MOLECULAR THERAPY (2010)
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
Federico Mingozzi et al.
BLOOD (2009)
Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts
Ursula Bantel-Schaal et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Worldwide Epidemiology of Neutralizing Antibodies to Adeno-Associated Viruses
Roberto Calcedo et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Striatal Readministration of rAAV Vectors Reveals an Immune Response Against AAV2 Capsids That Can Be Circumvented
Carmen S. Peden et al.
MOLECULAR THERAPY (2009)
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
J. M. Ruijter et al.
NUCLEIC ACIDS RESEARCH (2009)
Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients
Erik S. Stroes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
Amit C. Nathwani et al.
BLOOD (2007)
Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5
Michael A. Lochrie et al.
VIROLOGY (2006)
Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats
Jurgen Seppen et al.
MOLECULAR THERAPY (2006)
Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver
AC Nathwani et al.
BLOOD (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice
C. Riviere et al.
GENE THERAPY (2006)
New recombinant serotypes of AAV vectors
GP Gao et al.
CURRENT GENE THERAPY (2005)
Identification of PDGFR as a receptor for AAV-5 transduction
G Di Pasquale et al.
NATURE MEDICINE (2003)
Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment
U Bantel-Schaal et al.
JOURNAL OF VIROLOGY (2002)
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity
N Kaludov et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
